Search

Read about some of the biggest scientific discoveries made by MSK researchers in 2022.

… Wednesday, December 14, 2022 Researchers at Memorial Sloan Kettering Cancer Center (MSK) continued to make meaningful strides against cancer in 2022. Laboratory studies conducted at the Sloan Kettering Institute (SKI) Sloan Kettering Institute (SKI) and across the institution contributed to the global

Learn about the evolution of the Integrative Medicine Service (IMS) at Memorial Sloan Kettering, which was founded in 1999.

… Tuesday, December 24, 2019 Two women doing yoga together Yoga therapist Tina Paul (back) and Lori Weisenberg-Catalano work on form. Chief of the Integrative Medicine Service Jun Mao Chief of the Integrative Medicine Service Jun Mao performs acupuncture on a patient. Man playing guitar while child watches

Dr. Maciejowski studies chromosome instability and its role in cancer. In a May 2021 interview, he discussed how he got into science and what his lab has been focusing on lately.

… Tuesday, May 18, 2021 Molecular biologist John Maciejowski joined the faculty of the Sloan Kettering Institute in 2017 after completing his doctorate at MSK’s Gerstner Sloan Kettering Graduate School of Biomedical Sciences and his postdoctoral training at The Rockefeller University. He was in GSK’s first

The results of a large, international randomized trial herald a change in medical practice for the treatment of melanoma.

… Thursday, June 8, 2017 Summary A large study of nearly 2,000 people has answered an important question about the surgical treatment of melanoma , a type of skin cancer. For people with cancer detected in their sentinel lymph node, a watch-and-wait approach rather than immediate removal of all regional

A clinical trial provides evidence that blocking a protein called PI3K can be an effective treatment strategy for breast cancer.

… Saturday, June 2, 2018 Summary Researchers have hoped that drugs blocking a disease pathway called PI3K will slow breast cancer growth. Now a phase III clinical trial testing a drug called taselisib in combination with hormone therapy shows that this strategy can be effective. One of the most inviting

Physicians at Memorial Sloan Kettering Cancer Center (MSK) have developed and validated clinical calculators to help patients estimate their likelihood of avoiding a recurrence after treatment for colorectal cancer.

… Tuesday, November 8, 2022 Physicians at Memorial Sloan Kettering Cancer Center (MSK) have developed and validated clinical calculators to help patients estimate their likelihood of avoiding a recurrence after treatment for colorectal cancer. The newest calculator can help patients decide whether to proceed

Memorial Sloan Kettering Cancer Center (MSK) experts shared the results from cutting-edge advances in cancer research at the European Society of Medical Oncology (ESMO) Congress 2024, held in Barcelona, Spain, September 13 to 17, 2024.

… Tuesday, September 17, 2024 Memorial Sloan Kettering Cancer Center (MSK) experts shared the results from cutting-edge advances in cancer research at the European Society of Medical Oncology (ESMO) Congress 2024, held in Barcelona, Spain, September 13 to 17, 2024. Highlights included promising advances

A large cohort of patients with high-risk bladder cancer who underwent radical cystectomy and urinary tract reconstruction at Memorial Sloan Kettering Cancer Center reported favorable recovery and health-related quality of life within 24 months across most outcome measures.

… Tuesday, June 28, 2022 A large cohort of patients with high-risk bladder cancer who underwent radical cystectomy and urinary tract reconstruction at Memorial Sloan Kettering Cancer Center (MSK) reported favorable recovery and health-related quality of life (HRQOL) within 24 months across most outcome

Read our suggestions for getting through the holiday season while facing cancer.

… Tuesday, November 7, 2017 Summary The holiday season brings unique challenges for people with cancer. Social worker Jackie LaGrassa has tips for how to manage. The holidays are stressful enough. Having cancer can make for an especially trying season. “There are expectations that you’re going to show

Cancer knows no borders or languages. For most people newly diagnosed with cancer, it’s hard enough trying to understand their diagnosis, treatment options, and the life changes that lie ahead without also having to contend with a language barrier. The challenges are even more daunting for people facing an advanced, life-threatening disease.

… Wednesday, April 13, 2022 Cancer knows no borders or languages. For most people newly diagnosed with cancer, it’s hard enough trying to understand their diagnosis, treatment options, and the life changes that lie ahead without also having to contend with a language barrier. The challenges are even more